How should I convert a regimen of alprazolam 0.5 mg every 6 hours to an equivalent diazepam dose and then taper the diazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Converting Alprazolam to Diazepam and Tapering Strategy

Convert alprazolam 0.5 mg every 6 hours (2 mg total daily) to diazepam 20 mg daily (5 mg four times daily), then taper the diazepam by approximately 10% of the current dose every 1-2 weeks, extending the taper over several months with progressively smaller reductions as you approach lower doses.

Conversion Rationale

The standard benzodiazepine equivalency ratio is 1 mg alprazolam = 10 mg diazepam 1, 2. Your patient is taking:

  • Alprazolam 0.5 mg × 4 doses = 2 mg daily
  • This converts to 20 mg diazepam daily

Diazepam is the preferred agent for benzodiazepine tapering due to its long half-life (20-100 hours including active metabolites), which provides smoother plasma levels and reduces withdrawal severity 3, 2.

Initial Conversion Protocol

Start with diazepam 5 mg four times daily to match the alprazolam dosing schedule initially. After 2-3 days of stabilization, you can consolidate to twice or three times daily dosing given diazepam's longer half-life 1.

Critical Pitfall to Avoid

Do not abruptly switch—overlap is unnecessary given cross-tolerance, but monitor closely for the first 48-72 hours. Alprazolam has a shorter half-life (6-27 hours) than diazepam, so withdrawal symptoms may emerge 1-2 days after the last alprazolam dose if conversion is inadequate 4.

Diazepam Tapering Schedule

The taper should follow a hyperbolic (proportionate) reduction pattern, not linear reductions 5. This is pharmacologically critical because benzodiazepine receptor occupancy follows a hyperbolic curve—linear dose cuts produce exponentially larger pharmacological changes at lower doses.

Recommended Taper Algorithm:

Weeks 1-4: Reduce by 2 mg (10% of 20 mg) every 1-2 weeks

  • Week 0: 20 mg daily
  • Week 2: 18 mg daily
  • Week 4: 16 mg daily

Weeks 5-12: Reduce by 10% of the current dose every 1-2 weeks 6

  • Continue this pattern: 16 mg → 14.4 mg → 13 mg → 11.7 mg → 10.5 mg

Below 10 mg: Slow the taper to 5-10% reductions every 2-4 weeks 5

  • The final doses may need to be as small as 1 mg, 0.5 mg, or even 0.25 mg
  • Consider liquid diazepam formulation or compounded tablets for precise micro-dosing at very low doses 5

Key Principle

Each reduction should produce similar withdrawal intensity. If a patient tolerates a 2 mg reduction from 20 mg to 18 mg, the next reduction should be proportionally smaller (e.g., 1.8 mg from 18 mg to 16.2 mg) to produce equivalent pharmacological change 5.

Managing Withdrawal Symptoms

Monitor for withdrawal symptoms at each dose reduction 1:

  • Anxiety, insomnia, irritability (most common)
  • Tremor, sweating, muscle cramps
  • Perceptual disturbances
  • Seizures (rare but serious—more likely with doses >4 mg alprazolam equivalent or rapid tapers) 7

Adjunctive Medications for Withdrawal

If withdrawal symptoms are problematic 8:

  • Gabapentin or pregabalin for anxiety and insomnia
  • Trazodone 25-50 mg at bedtime for insomnia
  • Clonidine 0.1 mg twice daily (watch for hypotension) for autonomic symptoms
  • Avoid adding other benzodiazepines

When to Pause or Slow the Taper

Pause the taper if 1:

  • Severe withdrawal symptoms emerge
  • Patient becomes functionally impaired
  • New psychiatric symptoms develop

Resume at the previous tolerated dose, then attempt smaller reductions (5% instead of 10%) over longer intervals (3-4 weeks instead of 1-2 weeks).

Special Considerations

Total taper duration: Expect 3-12 months for a complete taper from this dose 6. Patients on benzodiazepines for years may require even slower tapers extending 12-24 months 5.

Protracted withdrawal syndrome: Some patients experience dysphoria, insomnia, and anxiety for weeks to months after complete discontinuation 1. This is distinct from acute withdrawal and requires supportive management, not re-institution of benzodiazepines.

Patient education is essential 6: Explain that temporary worsening of anxiety during tapering is expected and does not necessarily indicate treatment failure. The EMPOWER trial showed that 27% of patients successfully discontinued benzodiazepines when provided education about risks and gradual tapering support 6.

Related Questions

What is the equivalent dose of diazepam (alprazolam's generic equivalent is not needed here, but it is a benzodiazepine) for a patient taking 3mg of alprazolam (Xanax) daily?
What is the acute management for diazepam withdrawal?
How can I calculate a weekly dose of 10 mg of diazepam?
What is the equivalent oral diazepam dose for bromazepam 6 mg and how should the medication be switched?
Is a taper schedule of reducing diazepam from 30 mg daily to 25 mg for two weeks and then to 20 mg for the next two weeks an appropriate first‑month taper for a patient taking 30 mg daily?
In a 67-year-old man with hypertension, hyperlipidemia, and a 4 cm symptomatic ascending aortic aneurysm who presents with sudden stabbing chest pain radiating to the back, abdomen, and neck, a weaker left‑arm pulse, pallor, and faintness, which of the following statements is incorrect regarding the management of acute aortic dissection?
What is the appropriate management for a 3‑month‑old infant with MRSA‑positive purulent discharge from the right ear?
In a 3‑month‑old infant with methicillin‑resistant Staphylococcus aureus (MRSA) ear discharge, is oral linezolid appropriate for a ten‑day course?
What is the appropriate management for an infant with MRSA otorrhea and an ear swab positive for Aspergillus niger?
In a patient receiving bisphosphonate therapy who is scheduled for maxillary implant surgery, how long should the bisphosphonate be discontinued before and after the procedure, and what peri‑operative management is recommended?
Why might levothyroxine therapy fail to achieve the desired thyroid hormone effect?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.